KINGS CROSS SURGERY — All Prescriptions & Medications
Practice Code: F83635 | LONDON, NW1 1HY
Over the last 12 months, KINGS CROSS SURGERY prescribed 56,929 items across 391 different medications at a total cost of £479,451 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Fenofibrate | 10 | 280 | £28 | -89.7% ▼ |
| Zuclopenthixol hydrochloride | 10 | 1,100 | £138 | -68.3% ▼ |
| Domperidone | 10 | 370 | £8 | -72.0% ▼ |
| Erythromycin | 10 | 736 | £314 | -71.1% ▼ |
| Fludrocortisone acetate | 10 | 328 | £44 | -90.5% ▼ |
| Powder delisted probiotic (0913531) | 10 | 510 | £692 | +46.4% ▲ |
| Methotrexate | 10 | 564 | £32 | -96.9% ▼ |
| Pyridostigmine bromide | 10 | 2,000 | £161 | -41.6% ▼ |
| 10 | 935 | £93 | -45.4% ▼ | |
| 10 | 1,000 | £83 | -40.8% ▼ | |
| 10 | 300 | £1.1K | -77.9% ▼ | |
| Salmeterol | 11 | 11 | £306 | -54.3% ▼ |
| Clobazam | 11 | 322 | £35 | -83.3% ▼ |
| Biphasic insulin lispro | 11 | 100 | £618 | -74.4% ▼ |
| Ketone blood testing reagents | 11 | 320 | £287 | -83.7% ▼ |
| Hydrocortisone | 11 | 1,472 | £701 | -87.0% ▼ |
| Nafarelin acetate | 11 | 33 | £1.7K | +125.3% ▲ |
| Capsaicin | 11 | 669 | £322 | +39.3% ▲ |
| Dorzolamide | 11 | 145 | £104 | -86.8% ▼ |
| Clindamycin phosphate | 11 | 540 | £101 | -33.1% ▼ |
| Ivermectin | 11 | 555 | £322 | -48.3% ▼ |
| Metronidazole | 11 | 430 | £204 | -70.7% ▼ |
| 11 | 2,100 | £127 | -73.1% ▼ | |
| Amiodarone hydrochloride | 12 | 336 | £18 | -81.4% ▼ |
| Trazodone hydrochloride | 12 | 980 | £27 | -94.1% ▼ |
| Orlistat | 12 | 1,260 | £321 | -85.4% ▼ |
| Phenobarbital | 12 | 1,008 | £522 | -61.0% ▼ |
| Amantadine hydrochloride | 12 | 672 | £177 | -56.9% ▼ |
| Fosfomycin trometamol | 12 | 12 | £56 | -57.8% ▼ |
| Vildagliptin | 12 | 672 | £199 | -17.3% ▼ |
| Ready to serve 1 - 1.3 kcal/ml m/sk lower energy (0913011) | 12 | 180.0K | £2.4K | +72.2% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 12 | 360.0K | £8.5K | +25.1% ▲ |
| Timolol | 12 | 690 | £164 | -86.4% ▼ |
| 12 | 106 | £99 | -62.9% ▼ | |
| 12 | 174 | £70 | -88.3% ▼ | |
| 12 | 775 | £854 | +99.7% ▲ | |
| 12 | 1,052 | £98 | -40.7% ▼ | |
| 12 | 810 | £1.9K | -75.4% ▼ | |
| 12 | 1,138 | £96 | -76.0% ▼ | |
| Aluminium and magnesium and activated simeticone | 13 | 6,250 | £91 | +247.8% ▲ |
| Finerenone | 13 | 364 | £453 | +19.5% ▲ |
| Tirzepatide | 13 | 18 | £1.9K | -93.3% ▼ |
| Bicalutamide | 13 | 728 | £60 | -59.8% ▼ |
| Phytomenadione | 13 | 278 | £566 | +175.9% ▲ |
| Methyl salicylate | 13 | 840 | £75 | +53.7% ▲ |
| Clindamycin/tretinoin | 13 | 480 | £182 | +10.8% ▲ |
| 13 | 438 | £49 | -56.5% ▼ | |
| 13 | 129 | £656 | +227.9% ▲ | |
| 13 | 30 | £214 | -58.1% ▼ | |
| 13 | 2,230 | £226 | -73.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.